Lobbying Filing Details
Total Spending
$50,000
Activities
3
Lobbyists
3
Gov't Entities
6
Filing Information
- Filing UUID:
075918b8-436e-445d-976b-db3c78835d08- Type:
- Q1 - 1st Quarter - Report
- Period:
- 2025 - 1st Quarter (Jan 1 - Mar 31)
- Date Posted:
- April 17, 2025 at 7:30 PM
- Income:
- $50,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Jay B. Stewart
Registrant
HANCE SCARBOROUGH
Law Firm
Washington, District of ColumbiaClient
ALLIANCE FOR PHARMACY COMPOUNDING
Non-profit association promoting the practice of pharmacy compounding
Texas, United States of AmericaLobbying Activities (3)
Activity 1
Budget/AppropriationsIssues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act
Lobbyists (3)
- MICHAEL TOMBERLIN
- THERESA REED
- MR. ROBERT DAVID PORE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
Health IssuesIssues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act
Lobbyists (3)
- MICHAEL TOMBERLIN
- THERESA REED
- MR. ROBERT DAVID PORE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
PharmacyIssues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act
Lobbyists (3)
- MICHAEL TOMBERLIN
- THERESA REED
- MR. ROBERT DAVID PORE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES